Cleerly LABS vs Eko Foundation Analysis Software with Transformers (EFAST)

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 60/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.

AI Verdict

Cleerly LABS focuses on detailed coronary artery disease assessment using CCTA imaging, providing comprehensive plaque and stenosis analysis. In contrast, EFAST by Eko Health utilizes AI with digital stethoscopes for real-time detection of structural murmurs and atrial fibrillation during routine physical exams. While both are FDA-cleared cardiology AI tools, they address distinct clinical needs: Cleerly for advanced imaging diagnostics and EFAST for auscultation-based screening.

Choose Cleerly LABS if…

Choose Cleerly LABS if you require a comprehensive, non-invasive assessment of coronary artery disease using CT angiography. This tool is ideal for quantifying plaque burden, characterizing plaque types, and precisely detecting stenosis to inform personalized treatment plans. It is particularly well-suited for tracking disease progression over time and refining risk stratification.

View Cleerly LABS →

Choose Eko Foundation Analysis Software with Transformers (EFAST) if…

Choose Eko Foundation Analysis Software with Transformers (EFAST) if you need real-time, AI-powered assistance for detecting structural murmurs and atrial fibrillation during routine auscultation. This tool is best suited for clinicians seeking immediate, actionable cardiac insights at the point of care to aid in early screening and monitoring of common heart conditions during physical exams.

View Eko Foundation Analysis Software with Transformers (EFAST) →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature Cleerly LABS Eko Foundation Analysis Software with Transformers (EFAST)
Pricing Varies Subscription-based, contact for details
Deployment Cloud, On-premise Unknown
BAA Available Yes AI-estimated Yes AI-estimated
FDA Status Cleared AI-estimated Cleared AI-estimated
HIPAA Yes AI-estimated Yes AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

Eko Foundation Analysis Software with Transformers (EFAST)

EFAST offers real-time AI analysis during routine auscultation, integrating seamlessly with Eko digital stethoscopes for immediate insights at the point of care. This provides a more direct and accessible workflow for a broader range of clinicians compared to Cleerly LABS, which requires a separate CCTA imaging procedure and subsequent web-based analysis.

Clinical Value

Cleerly LABS

Cleerly LABS provides a comprehensive and detailed analysis of coronary CT angiography (CCTA) to detect, quantify, and characterize atherosclerosis and stenosis, including plaque volume and type, and can track disease progression over time. This offers a deeper, more personalized understanding of heart disease for long-term management and risk stratification.

Pricing & Value

Eko Foundation Analysis Software with Transformers (EFAST)

EFAST operates on a subscription-based model, which, combined with the relatively low daily cost of Eko's advanced stethoscope technology, likely presents a more predictable and potentially lower barrier to entry for routine clinical use. In contrast, Cleerly LABS has a high per-analysis cost, which, when combined with the separate CCTA scan cost, can result in substantial out-of-pocket expenses for patients.

Enterprise Readiness

Cleerly LABS

Cleerly LABS explicitly mentions an on-site Cleerly Proxy for data transfer and integration with PACS, RIS, and EHR systems, which are critical for seamless workflow within complex hospital and radiology environments. While EFAST offers EMR integration, Cleerly LABS's detailed integration strategy for imaging systems suggests a more robust readiness for large-scale enterprise deployment.

Innovation

Cleerly LABS

Cleerly LABS's innovation lies in its advanced AI-powered quantitative analysis of CCTA images to characterize coronary plaque beyond simple stenosis, including volume and type, and its ability to track disease progression. This represents a significant advancement in understanding and managing atherosclerosis for personalized heart disease management.

Support & Docs

Eko Foundation Analysis Software with Transformers (EFAST)

Eko Health provides a publicly accessible and structured support center with user manuals, FAQs, and articles specifically for EFAST and its related devices, indicating a comprehensive and readily available support system. While Cleerly offers support, the publicly available information on its specific documentation and support structure for LABS is less detailed.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature Cleerly LABS Eko Foundation Analysis Software with Transformers (EFAST)
Name Cleerly LABS Eko Foundation Analysis Software with Transformers (EFAST)
Company Cleerly Eko Health
Description AI-powered, FDA-cleared web-based software for comprehensive analysis of coronary CT angiography (CCTA) to detect, quantify, and characterize atherosclerosis and stenosis, aiding in personalized heart disease management. Advanced, FDA-cleared AI model that assists clinicians in identifying structural murmurs associated with heart disease and detecting atrial fibrillation, providing real-time, actionable cardiac insights during routine exams.
Primary Clinical Focus Coronary CT angiography (CCTA) analysis for atherosclerosis and stenosis detection, quantification, and characterization. Structural murmur detection and atrial fibrillation (AFib) detection during auscultation.
Key Features (Examples) AI-powered CCTA image analysis, Comprehensive coronary plaque assessment, Stenosis detection and quantification, 3D visualization of coronary arteries. AI-powered structural murmur detection, AI-powered atrial fibrillation (AFib) detection, Real-time AI analysis during auscultation, Enhanced audio with noise cancellation and amplification.

Videos

Demos, reviews, and walkthroughs featuring Cleerly LABS and Eko Foundation Analysis Software with Transformers (EFAST).

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

Cleerly LABS is an AI-powered web-based software for comprehensive analysis of coronary CT angiography (CCTA) to detect, quantify, and characterize atherosclerosis and stenosis, aiding in personalized heart disease management. EFAST by Eko Health is an AI model that assists clinicians in identifying structural murmurs associated with heart disease and detecting atrial fibrillation, providing real-time cardiac insights during routine exams.
Cleerly LABS requires coronary CT angiography (CCTA) images for its AI-powered analysis. EFAST utilizes real-time audio data from Eko digital stethoscopes during auscultation for its AI model to detect murmurs and atrial fibrillation.
Cleerly LABS detects, quantifies, and characterizes atherosclerosis and stenosis, and can detect ischemia with its Cleerly ISCHEMIA module. EFAST assists in identifying structural murmurs associated with heart disease and detects atrial fibrillation (AFib).
Cleerly LABS integrates with PACS, RIS, and EHR systems via an on-site Cleerly Proxy for data transfer. EFAST offers EMR integration for streamlined documentation and cloud-based recording and secure storage of exams.
Cleerly LABS is primarily aimed at Cardiology and Radiology specialties. EFAST is designed for use in Cardiology, Family Medicine, and Internal Medicine.

Backers

Who funded each tool's parent company.

AI Tool Finder
AI-powered search. Results may not be comprehensive.